Prescription Patterns for Patients With Obsessive-Compulsive Disorder in Psychiatry Clinics in Addis Ababa: A Retrospective Multicenter Study.
No Thumbnail Available
Date
2026
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa Uinverstiy
Abstract
Background: Treatment guidelines for OCD recommend selective serotonin reuptake
inhibitors (SSRIs) as first-line agents and Clomipramine as a second-line option.
Several studies and the APA guideline indicate that higher doses of SSRIs are needed
for adequate treatment of OCD compared to doses used in conditions like depression.
Despite the evidence for high-dose SSRIs, surveys have shown that very few patients
often receive evidence-based treatment.
Objectives: To describe the prescription pattern and identify factors that influence the
pattern.
Methods: A retrospective chart review was conducted on 213 cases seen from January
1,2021 up to December 31,2025, in three public and two private institutions. Age,
duration since diagnosis, academic background of prescribers and study settings were
independent variables, while prescription pattern was the dependent variable. SPSS
version 29 was used. Descriptive analysis and ANOVA were done.
Results: Nine out of ten (90.8%) of the patients were treated with medications. SSRIs
were prescribed as first-line for 77.7% and Clomipramine for 13.9%. Fluoxetine was
the most prescribed first-line SSRI (66.7%) followed by sertraline (32.7%). Sertraline
and Clomipramine were prescribed first-line by senior psychiatrists in 75.5% and 70.4%
of cases respectively, while fluoxetine was prescribed first-line by residents in 52%.
Two of the five study settings accounted for 85.9% of the first-line clomipramine
prescriptions. The maximum prescribed doses of fluoxetine and sertraline were in
range of low to medium doses for 68.3% and 83.4% respectively. In cases where
medications were changed, the change occurred in ≤12 weeks for 47% on fluoxetine
and 50% on sertraline. Objective clinical scales were used in 13.1%. Medication side
effects were reported by 32.1% and 23.8% had a history of medication discontinuation.
Psychotherapy was done for 40.4% of the patients. Several clinical variables were
undocumented.
Conclusion and Recommendation: The prescribed first-line medications generally
align with established guidelines. However, the maximum doses of SSRIs are
predominantly within the low to medium range for most patients. It is important to
consider factors such as symptom severity when determining dosage. To enhance
treatment outcomes, comprehensive documentation, the use of objective clinical
scales, and staying current with treatment guidelines are strongly recommended.
Description
Keywords
Obsessive compulsive disorder, prescription pattern, selective serotonin reuptake inhibitors, clomipramine.